Cellular, molecular and functional characterization of quiescence in Leishmania donovani, the etiological agent of visceral leishmaniasis

Dujardin, J. – Molecular Parasitology

Fonds voor Wetenschappelijk Onderzoek

1/01/21 → 31/12/24

‍

Viral evolutionary analyses as a magnifying glass on parasite population dynamics

Dujardin, J. – Molecular Parasitology

Fonds voor Wetenschappelijk Onderzoek

1/01/21 → 31/12/24

‍

Clinical research platform for untargeted RNA virus detection in tropical fever patient populations: construction and application

Vercauteren, K. – Clinical Virology

Flemish Government – Department of Economy, Science & Innovation (SOFI)

1/01/21 → 31/12/24

‍

Improving leprosy prevention strategies by integrating social network analysis with spatial and molecular epidemiology data of Mycobacterium leprae in the Comoros

Peeters, K. – Socio-ecological Health Research

Flemish Government – Department of Economy, Science & Innovation (SOFI)

1/01/21 → 31/12/24

‍

Innovate to reduce rifampicin-resistant tuberculosis in Rwanda and beyond (InnoR3TB)

De Jong, B. - Mycobacteriology

Flemish Government – Department of Economy, Science & Innovation (SOFI)

1/01/21 → 31/12/24

‍

Mechanisms of P. vivax chloroquine resistance: a transcriptomic/transgenic approach

Rosanas-Urgell, A. - Malariology

Flemish Government – Department of Economy, Science & Innovation (SOFI)

1/01/21 → 31/12/24

‍

PReventing the Emergence of untreatable STIs via radical Prevention

Kenyon, C. – Sexual Transmitted Diseases

Flemish Government – Department of Economy, Science & Innovation (SOFI)

1/01/21 → 31/12/24

‍

Spatial analysis of host-parasite interactions in the skin across the clinical spectrum of cutaneous leishmaniasis in Ethiopia

Adriaensen, W. – Clinical Immunology

Stichting Dioraphte

1/01/21 → 31/12/23

‍

Development and evaluation of a computerized intervention for chemsex support

Florence, E. – HIV/STD Clinic

VAD vzw

19/11/20 → 31/03/21

‍

Unravelling Data for Rapid Evidence-Based Response to COVID-19

Peñalvo, J. L. – Non-Communicable Diseases

European Commission

15/11/20 → 14/11/22

‍

Celluloepidemiologie: genereren en modelleren van SARS-COV-2 specifieke T-cel responsen op populatieniveau met als doel interventies in de gezondheidszorg te verbeteren

Ariën, K. - Virology

Fonds voor Wetenschappelijk Onderzoek

1/11/20 → 31/10/21

‍

Diagnostica TRYPELIM

Hasker, E. – Tropical Infectious Diseases

Bill & Melinda Gates Foundation

1/11/20 → 31/01/22

‍

Pro-actively addressing the challenges for an effective uptake of COVID-19 vaccination in Belgium: a transdisciplinary approach.

Peeters, K. – Socio-ecological Health Research

Fonds voor Wetenschappelijk Onderzoek

1/11/20 → 31/10/21

‍

Mucine isovorm-microbioom interacties die de ernst van COVID19 bepalen: een hulp bij de stratificatie van patiënten?

Ariën, K. - Virology

Fonds voor Wetenschappelijk Onderzoek

1/11/20 → 31/10/21

‍

Msichana/Chakti! Understanding accountability in sexual and reproductive health of adolescent girls living in slums: a realist evaluation

Van Belle, S. – Health Policy

Fonds voor Wetenschappelijk Onderzoek (Postdoctoraal mandaat)

1/11/20 → 31/10/2023

‍

Gaming for Health – A mixed methods approach using the pork tapeworm as a model

Trevisan, C. – Veterinary Helminthology

Fonds voor Wetenschappelijk Onderzoek (Postdoctoraal mandaat)

1/11/20 → 31/10/2023

‍

Assessing replicative fitness difference of SARS-CoV-2 circulating lineages

Bartholomeeusen, K. - Virology

Flemish Government – Department of Economy, Science & Innovation (Pump Priming Projects)

20/10/20 → 20/07/21

‍

Chemified: pilot testing of a mobile application for chemsex-care and support

Florence, E. – HIV/STI Clinic

Flemish Government – Department of Economy, Science & Innovation (Pump Priming Projects)

20/10/20 → 20/07/21

‍

Data integration to close the gap on Prediction of MTB Drug Resistance Mutations

de Jong, B. - Mycobacteriology

Flemish Government – Department of Economy, Science & Innovation (Pump Priming Projects)

20/10/20 → 20/07/21

‍

Diagnosis through Sorted Immune Repertoires

Vercauteren, K. – Clinical Virology

Flemish Government – Department of Economy, Science & Innovation (Pump Priming Projects)

20/10/20 → 20/07/21

‍

Documenting stillbirths and early neonatal deaths to improve maternal and newborn health in Cambodia

Benova, L., Delvaux, T. – Sexual and Reproductive Health

Flemish Government – Department of Economy, Science & Innovation (Pump Priming Projects)

20/10/20 → 20/07/21

‍

ID-CoV: Identification of predictive models of COVID-19 severity in a multi-state setting for its use in risk stratification

Peñalvo, J. L. – Non-Communicable Diseases

Flemish Government – Department of Economy, Science & Innovation (Pump Priming Projects)

20/10/20 → 20/07/21

‍

Prospective investigation of oxidative stress in West Nile virus infection

Bottieau, E. – Tropical Diseases

Flemish Government – Department of Economy, Science & Innovation (Pump Priming Projects)

20/10/20 → 20/07/21

‍

Single cell transcriptomics of Leishmania donovani throughout its development in its natural sand fly vector Phlebotomus argentipes (LEISH-ILIAD*)

Dujardin, J., Domagalska, M. – Molecular Parasitology

Flemish Government – Department of Economy, Science & Innovation (Pump Priming Projects)

20/10/20 → 20/07/21

‍

The impact of immunometabolomic dynamics in Plasmodium sexual conversion rates

Rosanas-Urgell, A. - Malariology

Flemish Government – Department of Economy, Science & Innovation (Pump Priming Projects)

20/10/20 → 20/07/21

‍

Beter begrijpen van Covid-19 uitbraken in Woonzorg centra (WZC) in Vlaanderen, een epidemiologisch onder- zoek

Laga, M. - Sexual Health incl HIV

MVG, Prevent.& Soc.Gezond.Zorg

1/10/20 → 31/03/21

‍

Impact Covid-19 on Maternal Health

Benova, L. – Sexual and Reproductive Health

British Embassy

1/10/20 → 31/03/21

‍

Ondersteunen van inzage verkrijgen in de transmissie- dynamiek van SARS-CoV-2 in de Brusselse regio en het vroeg detecteren van clusters

Laga, M. – Sexual Health incl HIV

Gezondheid & Welzijn Brussels Gewest

1/10/20 → 31/03/21

‍

Vaccine Hesitancy during COVID-19 Misinformation

Peeters, K. – Socio-ecological Health Research

British Embassy

1/10/20 → 31/03/21

‍

PICOV study: "Influence of prior infection with COVID-19 on occurence of influenza-like illness or acute respiratory infection"

Ariën, K. - Virology

Sciensano

24/09/20 → 31/05/21

‍

Master Clinical Study An open-label, multicentre, randomized adaptive platform trial of the safety and efficacy of several therapies, including antiviral therapies, versus control in mild / moderate cases of COVID-19

van Griensven, J. – HIV & Neglected Tropical Diseases

DNDi Geneva

1/09/20 → 31/10/22

‍

Preventie van Diabetes type 2 en zwangerschapsdiabetes bij vrouwen van reproductieve leeftijd in Kisantu, DR Congo

Peñalvo, J. L. – Non-Communicable Diseases

Het college van burgemeester

1/09/20 → 31/08/21

‍

Exploring and learning from evidence, policy and systems responses to COVID-19 in West and Central Africa

Van Damme, W. – Health Policy

International Development

‍

1/08/20 → 31/07/22

Is screening for gonorrhea and chlamydia cost-effective in reducing the cumulative incidence of these infections in men who have sex with men taking HIV pre-exposure prophylaxis (PrEP): a randomized, multicenter controlled trial

Kenyon, C. - Sexual Transmitted Diseases

Federaal Kenniscentrum België

1/07/20 → 30/06/23

‍

Sero-prevalence and sero-conversion study of health care workers and their households, Democratic Republic of the Congo

Vanlerberghe V., - Tropical Infectious Diseases

Deutsche Gesellshaft Fur Internationale Zusammenarbeit

1/07/20 → 31/01/21

‍

AfriCover: Characterising transmission parameters of SARS-CoV-2 in a peri-urban setting in Mozambique using population-based surveillance and a high-throughput sero-assay

Widdowson, M. – Outbreak Research Team

European & Developing Countries Clinical Trials Partnership

15/06/20 → 14/09/21

‍

Emerging Infectious Diseases Research Center - East and Central Africa

Hasker, E., Vanlerberghe V. – Tropical Infectious Diseases

US National Institutes of Health

1/06/20 → 31/05/25

‍

ImmCoV: Are SARS-CoV-2 specific antibodies a correlate for protection?

Ariën, K. - Virology

Fonds voor Wetenschappelijk Onderzoek

22/05/20 → 31/05/21

‍

Severe Typhoid in Africa PLUS Program

Jacobs, J. – Tropical Bacteriology

International Vaccine Institute

1/05/20 → 30/04/21

‍

SARS-CoV-2 HCW study: SARS-CoV-2 prevalence, seroprevalence and seroconversion among healthcare workers in Belgium during the 2020 COVID-19 outbreak

Ariën, K. - Virology

Sciensano

22/04/20 → 30/04/21

‍

Health Systems Transformation India

Criel, B. – Equity and Health

Access Health

1/04/20 → 30/06/21

‍

The clinically silent Plasmodium vivax reservoir in the Amazon: a systematic review and pooled analysis of individual-level data from population-based surveys

Rosanas-Urgell, A. - Malariology

Fonds voor Wetenschappelijk Onderzoek

1/04/20 → 31/03/22

‍

Bacteriële groei voor diagnosis van bloedbaan infecties in ontwikkelingslanden

Jacobs, J. – Tropical Bacteriology

Fonds voor Wetenschappelijk Onderzoek

1/01/20 → 31/12/21

‍

Development and validation of a novel life course microsimulation model linking diet to noncommunicable diseases

Peñalvo, J. L. – Non-Communicable Diseases

Fonds voor Wetenschappelijk Onderzoek

1/01/20 → 31/12/23

‍

Heteroresistance: an occult threat to the treatment success of resistant tuberculosis

de Jong, B. – Mycobacteriology

Fonds voor Wetenschappelijk Onderzoek

1/01/20 → 31/12/23

‍

Identifying sylvatic reservoir species of outbreak-prone arthropodborne viruses through large-scale serostatus mapping in African wildlife

Ariën, K. - Virology

Fonds voor Wetenschappelijk Onderzoek

1/01/20 → 31/12/23

‍

Diversity Components in Mosquito-Borne Diseases in Face of Climate Change

Müller, R. – Medical Entomology

Fonds voor Wetenschappelijk Onderzoek

1/03/20 → 28/02/23

‍

Action Leveraging Evidence to Reduce perinatal mortality and morbidity in sub-Saharan Africa

Benova, L. – Sexual and Reproductive Health

European Commission

1/01/20 → 31/12/24

‍

Community-based tuberculosis triage testing after symptom screening in hard-to-reach African populations: CAD4TB versus C-reactive protein

Lynen, L. – HIV/AIDS

European & Developing Countries Clinical Trials Partnership

1/01/20 → 31/12/23

‍

Heteroresistentie: occulte bedreiging voor succesvolle behandeling van resistente tuberculosis.

de Jong, B. - Mycobacteriology

Fonds voor Wetenschappelijk Onderzoek

1/01/20 → 31/12/23

‍

Identificeren van reservoir soorten voor virussen die door insecten worden overgedragen door middel van grootschalige analyse van de serostatus in Afrikaanse wilde dieren.

Ariën, K. - Virology

Fonds voor Wetenschappelijk Onderzoek

1/01/20 → 31/12/23

‍

Monitoring Outbreak events for Disease surveillance in a data science context

Müller, R. & Van Bortel W. – Medical Entomology

European Commission

1/01/20 → 31/12/23

‍

Examining barriers to providing good quality postnatal care: A mixed-methods study of global configurations of care and local clinical practice adaptations in Tanzania and Guinea.

Benova, L. – Sexual and Reproductive Health

Fonds voor Wetenschappelijk Onderzoek (Postdoctoraal mandaat)

1/11/19 → 31/10/22

‍

Diagnostic performance evaluation of the Genoscholar TM-PZA-TB II

de Jong, B. - Mycobacteriology

Foundation for Innovative New Diagnostics (FIND)

25/10/19 → 31/10/21

‍

Advancing a GMMA-based vaccine against invasive non-typhoidal salmonellosis through Phase I trial in Europe and sub-Saharan Africa

Jacobs, J. – Tropical Laboratory Medicine

European Commission

1/10/19 → 31/03/21

‍

Onthullen van fenotypische en moleculaire eigenschappen van het slaap fenotype bij Leishmania populaties onder medicijnen druk

Jara M. – Molecular Parasitology

Fonds voor Wetenschappelijk Onderzoek (Postdoctoraal mandaat)

1/10/19 → 30/09/22

‍

Prise en charge améliorée de Maladie à Virus Ebola en situation d'urgence en RDC

Ariën, K. - Virology

European & Developing Countries Clinical Trials Partnership

1/09/19 → 31/08/21

‍

Is screening for gonorrhea and chlamydia cost-effective in reducing the cumulative incidence of these infections in men who have sex with men taking HIV pre exposure prophylaxis (PrEP): a randomized, multicenter controlled trial

Kenyon, C. -  Sexual Transmitted Diseases

Federaal Kenniscentrum voor Gezondheidszorg.

15/09/19 → 31/08/20

‍

Development and evaluation of a computerized intervention for chemsex (Chemified study)

Florence, E. – HIV/STD Clinic

1/09/19 → 31/12/20

‍

Effectiveness and tolerability of a short regimen for drug resistant tuberculosis treatment in Kandahar Province, Afghanistan, Uncontrolled Clinical Study

de Jong, B. - Mycobacteriology

MSF NEDERLAND

1/09/19 → 30/04/22

‍

Pilot clinical bacteriology in the Ebola Viral Disease (EVD) care response to detect intercurring bloodstream infections and inform about appropriate antibiotic treatment

Jacobs, J. – Tropical Bacteriology

Elrha

1/08/19 → 30/04/20

‍

Preventing vector-borne disease outbreaks in emergent peri-urban settings: a transdisciplinary study on the Integrated Housing Development Programme in Jimma, Ethiopia

Peeters, K. – Socio-ecological Health Research

Biotechnology and Biological Sciences Research Council UK

1/07/19 → 30/06/20

‍

People-centered digitized healthcare system: Using technology as a platform to strengthen the continuum of care in Kibaha, Tanzania

Peeters, K. – Socio-ecological Health Research

D-tree International

1/04/19 → 30/09/21

‍

Enhancing entomological capacity for combating vector borne diseases in Nepal

Müller, R – Medical Entomology

Bill & Melinda Gates Foundation

26/03/19 → 1/09/20

‍

Treatment of Rifampin-resistant Tuberculosis with an All-Oral Regimen containing new drugs in Zhytomyr Ukraine

de Jong, B. - Mycobacteriology

MSF Belgium

1/03/19 → 31/08/21

‍

Effect of a novel typhoid conjugate vaccine in Africa: a multicenter study in Ghana and the DRC

Jacobs, J. – Tropical Bacteriology

European & Developing Countries Clinical Trials Partnership

1/01/19 → 31/12/23

‍

Optimise PrEP to Maximise Impact

Laga, M. – Sexual Health incl HIV

Fonds voor Wetenschappelijk Onderzoek

1/01/19 → 31/12/22

‍

Scaling-up of evidence-based health interventions at population level for the prevention and management of hypertension and/or diabetes

Van Damme, W. – International Health Policy

European Commission

1/01/19 → 31/12/22

‍

Cryptic human and animal reservoirs compromise the sustainedelimination of gambiense-human African trypanosomiasis in the Democratic Republic of the Congo

Büscher, P. – Diagnostic Parasitology

Flemish Government - Department of Economy, Science & Innovation (SOFI)

1/12/18 → 30/11/23

‍

A systemic insecticide to control zoonotic cutaneous leishmaniasis in Errachidia province - Southeastern Morocco: an intervention trial for an innovative vector control tool

Boelaert, M. – Epidemiology and Control of Neglected Tropical Diseases

Flemish Government - Department of Economy, Science & Innovation (SOFI)

1/11/18 → 31/10/22

‍

A proof-of-concept trial to evaluate artesunate-mefloquine as a novel alternative treatment for schistosomiasis in African children

Bottieau, E. – Tropical Medicine

Flemish Government - Department of Economy, Science & Innovation (SOFI)

1/10/18 → 30/09/22

‍

Aneuploidy and mosaicism: a strategy for early adaptation to drug pressure in Leishmania

Dujardin, JC. – Molecular Parasitology

Flemish Government - Department of Economy, Science & Innovation (SOFI)

1/10/18 → 31/12/23

‍

Development of a high-throughput inhibition ELISA to replace immune trypanolysis for post-elimination monitoring of gambiense-HAT II

Büscher, P. – Diagnostic Parasitology

Bill & Melinda Gates Foundation

1/10/18 → 30/09/20

‍

Novel high-dose tuberclosis retreatment regimens: How to overcome resistance without creating more?

Decroo, T. – HIV/AIDS

Fonds voor Wetenschappelijk Onderzoek (Postdoctoraal Mandaat)

1/10/18 → 30/09/21

‍

Novel High-Dose Tuberculosis Retreatment Regimens: How to overcome resistance without creating more?

Lynen, L. – HIV/AIDS

Flemish Government - Department of Economy, Science & Innovation (SOFI)

1/10/18 → 30/09/24

‍

Preventing Resistance in Gonorrhoea Study

Kenyon, C. - Sexual Transmitted Diseases

Fonds voor Wetenschappelijk Onderzoek

1/10/18 → 30/09/22

‍

Whole Genome Sequencing to streamline TB diagnosis, improve TB surveillance and optimize individualized TB treatment a pragmatic trial

Rigouts, L. - Mycobacteriology

Fonds voor Wetenschappelijk Onderzoek

1/10/18 → 30/09/22

‍

Post exposure prophylaxis for leprosy in the Comoros and Madagascar

de Jong, B. - Mycobacteriology

European & Developing Countries Clinical Trials Partnership

1/09/18 → 31/08/22

‍

la PrEP comme nouvel outil pour la prévention du VIH combinéune étude qualitative complémentaire d'un projet de démonstration de la PrEP en cours chez les HSH en Afriquede l'Ouest

Laga, M. – Sexual Health incl HIV

A.N.R.S. Agence Nationale de Recherche

1/08/18 → 31/07/21

‍

A study of the dynamics between sexual risk behavior, social context and the use of Pre-Exposure Prophylaxis among men who have sex with men: longitudinal and international mixed-method research

Reyniers, T. – International HIV/AIDS policy

Fonds voor Wetenschappelijk Onderzoek (Postdoctoraal mandaat)

1/10/18 → 30/09/21

‍

Operational research to sustain VL elimination and break transmission in India

Boelaert, M. – Epidemiology and Control of Neglected Tropical Diseases

Bill & Melinda Gates Foundation

1/07/18 → 31/07/20

‍

A multi-disciplinary international effort to identify clinical, molecular and social factors impacting cutaneous leishmaniasis

Dujardin, JC. – Molecular Parasitology

European Commission

1/04/18 → 31/03/22

‍

Development of a small-scale, quality-assured, stand-alone, and transportable clinical bacteriology laboratory

Jacobs, J. – Tropical Bacteriology

MSF France

1/03/18 → 31/12/20

‍

Immuno Cytometry: Phenotyping immune cellular components, in the context of HBV, HIV and AD, by new, advanced technologies

Vanham, G. - Virology

Agentschap voor Innovatie door Wetenschap en Technologie

18/01/18 → 17/08/20

‍

Anthropological research and community participation to facilitate mass drug administration of iverctmetin and dyhidroartemisin-piperaquine as an additional intervention for malaria elimination

Peeters, K. – Socio-ecological Health Research

Medical Research Council, UK

1/01/18 → 30/09/20

‍

Identification of epitopes in the alphaviral envelope that confer infectivity for human and mosquito cells

Bartholomeeusen, K. - Virology

Fonds voor Wetenschappelijk Onderzoek (Krediet aan Navorsers)

1/01/18 → 31/12/20

‍

Role of human movement in relation to popular spots in the spatiotemporal dimension of vectorial arbovirus transmission?

Vanlerberghe, V – Tropical Infectious Diseases
Fonds voor Wetenschappelijk Onderzoek (Krediet aan Navorsers)
1/01/18 → 31/12/19

‍

Access to Pre-exposure Prophylaxis for Men Who Have Sex With Men: Acceptability and Feasibility in Community-based Clinics in West Africa

Laga, M. – Sexual Health incl HIV

The Global Fund to fight AIDS

1/12/17 → 30/11/20

‍

African CoaLition for Epidemic Research, Response and Training

van Griensven, J. – HIV & Neglected Tropical Diseases

European & Developing Countries Clinical Trials Partnership

1/12/17 → 30/11/22

‍

Persistent T-cell dysfunction in synergistic VL-HIV co-infection

Adriaensen, W. – HIV & Neglected Tropical Diseases

Fonds voor Wetenschappelijk Onderzoek (Postdoctoraal Mandaat)

1/10/17 → 30/09/20

‍

Development of specific and highly sensitive mulit-pathogen laboratory tests for the simultaneous and differential detection of arthropod-borne viruses

Ariën, K. - Virology

Agentschap voor Innovatie door Wetenschap en Technologie

1/08/17 → 31/07/20

‍

Visceral Leishmaniasis in Bihar State, India

Boelaert, M. – Epidemiology and Control of Neglected Tropical Diseases

US xNational Institutes of Health – Tropical Medicine Research Centers

1/08/17 → 31/03/22

‍

Monitoring van exotische steekmuggen in België

Van Bortel, W., Coosemans, M. & Deblauwe, I. – Medical Entomology

Vlaamse, Waalse en Brusselse overheden en de FOD Volksgezondheid, Veiligheid van de Voedselketen

1/07/17 → 30/04/21

Designing and evaluating provider results-based financing for tuberculosis care in Georgia: understanding costs, mechanisms of effect and impacts

Marchal, B. – Health Systems

MRC/ESRC/DfID/Wellcome Trust, United Kingdom

1/03/17 → 1/03/21

‍

Hepatitis C virus direct acting antiviral (DAA) treatment success and its impact on transmission dynamics in HIV/HCV co-infected MSM

Buvé, A. – International HIV/AIDS Policy

Fonds voor Wetenschappelijk Onderzoek

1/01/17 → 31/12/20

‍

R2STOP Leprosy: Improved understanding of ongoing transmission of leprosy in the Comoros, a region hyperendemic for the disease

de Jong, B. - Mycobacteriology

Research to Stop

1/01/17 → 31/12/20

‍

Kinetoplast genomics for the fine-scale study of hybrid zones in eukaryote parasites

Van den Broeck – Molecular Parasitology

Fonds voor Wetenschappelijk Onderzoek (Postdoctoraal Mandaat)

1/01/17 → 30/06/20

‍

Young Women and HIV in Africa

Laga, M. – Sexual Health incl HIV

Fondation de Luxembourg

1/01/17 → 1/02/22

‍

Eliminating Human African Trypanosomiasis in the three (formerly) Bandundu provinces, the Democratic Republic of Congo.

Boelaert, M. – Epidemiology and Control of Neglected Tropical Diseases

Bill & Melinda Gates Foundation

1/11/16 → 31/12/21

‍

Zika Preparedness Latin American Network Adressing the urgent research gaps against the Zika virus and other emerging threats in Latin America

Ariën, K. - Virology

European Commission

1/10/16 → 30/09/20

‍

Evaluation of an antibody detecting point-of-care test for the detection of Taenia Solium Taeniasis and (neuro) cysticercosis in communities and primary care settings of highly endemic, resource-poor areas in Tanzania and Zambia, including training of- and technology transfer to the regional Reference Laboratory and health centres

Dorny, P. – Veterinary Helminthology

European & Developing Countries Clinical Trials Partnership

1/09/16 → 31/08/20

‍

Culture free diagnosis and follow-up of multidrug resistant tuberculosis patients

de Jong, B. - Mycobacteriology

European & Developing Countries Clinical Trials Partnership

1/06/16 → 31/05/21

‍

Diagnostic tools for human African trypanosomiasis elimination and clinical trials

Büscher, P. – Diagnostic Parasitology

European & Developing Countries Clinical Trials Partnership

1/02/16 → 31/01/21

Developing, Testing and Optimizing Patient Education and Counseling in HIV Prevention through Digital Self-Managementand Group Counseling among Men having Sex with Men

Laga, M. – Sexual Health incl HIV

Koning Boudewijnstichting

1/01/16 → 31/03/20

‍

Rationeel ontwerp van een therapeutisch vaccin tegen HIV-1 gebaseerd op een nieuwe formulering van nanopartikel

Vanham, G. - Virology

Fonds voor Wetenschappelijk Onderzoek

1/01/16 → 31/12/20

‍

The evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with MDR-TB.

de Jong, B. - Mycobacteriology

Vital Strategies

1/10/15 → 30/06/22

‍

Evaluating mHealth technology in HIV to improve Empowerment and healthcare utilisation: Research and innovation to Generate Evidence for personalised care

Florence, E. – HIV/STD Clinic

European Commission

1/05/15 → 30/04/20

‍

Renforcement Institutionnel pour des Politiques de Santé basées sur l'Evidence en République Démocratique du Congo

Criel, B. – Health Financing

European Commission Europe Aid

24/12/14 → 23/12/20

‍

Taenia solium elimination

Dorny, P. – Veterinary Helminthology

Flemish Government - Department of Economy, Science & Innovation (SOFI)

1/09/14 → 31/08/20

‍

Predicting visceral leishmaniasis in HIV infected patients: how to screen and who to treat?

van Griensven, J. – HIV & Neglected Tropical Diseases

Flemish Government - Department of Economy, Science & Innovation (SOFI)

1/07/14 → 31/07/21

‍

A multi-omic approach to characterize gene dosage compensation in Leishmania

Cuypers, B. – Molecular Parasitology

Fonds voor Wetenschappelijk Onderzoek (Postdoctoraal mandaat)

1/10/18 → 30/09/21

‍

Supporting Policy Engagements for Evidence Based Decisions for Universal Health Coverage in Uganda

Criel, B. – Equity & Health

van de Pas, R. – Health Policy

European Commission Europe Aid Co-operation Office

1/03/15 → 29/02/20